ABL1 and acute lymphoblastic leukemia: To more directly investigate the involvement of BCR::ABL1 in higher CD49f expression levels in Ph‐positive leukemia cells, we analyzed two pairs of Ph‐positive ALL cell lines, that is, the parental lines and their T315I acquired imatinib‐resistant sublines.